Archive: Pharmaceutical

MedImmune Starts Shipping FluMist

Ignore the sweltering heat and humidity. MedImmune is telling us to start preparing for the winter flu season. MedImmune, the Gaithersburg biotech division of British drugmaker AstraZeneca, began shipping out its flu vaccine nasal spray, FluMist, Thursday -- nearly three months ahead of its typical schedule. In the past, manufacturers...

By Terri Rupar | August 5, 2008; 09:00 AM ET | Comments (0)

PRA To Relocate to North Carolina

PRA International, the Reston company specializing in running clinical trials, announced today it is relocating to Raleigh, N.C. The move will cost the Washington region a few dozen jobs, all of which were in corporate and administration work. "After conducting a comprehensive analysis, we have determined that relocating to the...

By Dan Beyers | September 25, 2007; 03:55 PM ET | Comments (0)

Sucampo Seeks Additional FDA Approvals

Sucampo Pharmaceuticals, a Bethesda drugmaker that went public last month, announced today that the Food and Drug Administration has accepted the firm's application seeking additional approval of its treatment for constipation. See the company's release. Sucampo last year received approval from the FDA to market Amitiza, a treatment for chronic...

By Mike Shepard | September 18, 2007; 02:02 PM ET | Comments (0)

Nabi to Shift Headquarters to Rockville After Sale

Nabi Biopharmaceuticals, a maker of plasma products with research facilities in Maryland, announced today the sale of its main operations in Boca Raton, Fla., to German drug manufacturer Biotest AG for $185 million. See Nabi's statement Once the transaction is completed, Nabi said it plans to move its headquarters from...

By Mike Shepard | September 11, 2007; 02:28 PM ET | Comments (0)

Private Equity Firm Buys PRA International

PRA International, a clinical research company based in Reston, said it has agreed to be bought by private equity firm Genstar Capital in a deal valued at $790 million. Under the terms of the agreement, PRA stockholders will be entitled to receive $30.50 in cash for each share of PRA...

By Dan Beyers | July 25, 2007; 06:48 AM ET | Comments (0)

RSS Feed
Subscribe to The Post

© 2010 The Washington Post Company